Pain management in acute pancreatitis Signs and Symptoms
Conditions
Interventions
There will be no change in the clinical course for the participants in this trial given this is a observational study. The patients will be followed for 1 month post recruitment to record any complica
Sponsors
Newcastle upon Tyne Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and above 2. First presentation with acute pancreatitis of any etiology
Exclusion criteria
Exclusion criteria: 1. Recurrent acute pancreatitis 2. Chronic pancreatitis 3. Post ERCP pancreatitis (will have been given prophylactic NSAIDs) 4. Those on regular opioids, trycyclic antodipressaants and gabapentinoids for other painful conditions, including chronic pain (for other reasons) 5. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesics used during admission (i.e. simple analgesics, mild opioids, strong opioids and epidural analgesia) are measured using patient records at a single timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| Local and systemic complications of AP measured using patient records at a single timepoint (1 month after admission) | — |
Countries
Argentina, Australia, China, Cyprus, Denmark, Egypt, England, Georgia, Greece, India, Italy, Jordan, Kyrgyzstan, New Zealand, Pakistan, Portugal, Romania, Scotland, Serbia, Singapore, South Africa, Spain, Sri Lanka, Sudan, Türkiye, Ukraine, United Kingdom, United States of America, Wales
Outcome results
None listed